Recombinant Chicken PRPH2 is synthesized using heterologous expression systems, including E. coli, yeast, baculovirus, or mammalian cells . The protein is purified to ≥85% purity via SDS-PAGE .
| Host Systems | Purity | Applications |
|---|---|---|
| E. coli | ≥85% | Structural studies, bioassays |
| Baculovirus | ≥85% | Functional assays, protein complexes |
| Mammalian Cells | ≥85% | Post-translational modification studies |
PRPH2 overexpression in Rom1−/− mice rescues OS disc enclosure defects, demonstrating its redundancy with ROM1 in OS morphogenesis . Overexpression of PRPH2 (30% above wild-type levels) restores normal disc structure in Rom1−/− retinas .
Chicken polyclonal antibodies against PRPH2 are used in:
Western Blot (WB): 1:20,000 dilution to detect PRPH2 in rat retina/eye tissue .
Immunofluorescence (IF/ICC): 1:2,000–5,000 dilution for localization studies .
| Antibody Characteristics | Details |
|---|---|
| Immunogen | Recombinant rat PRPH2 (E. coli) |
| Cross-Reactivity | Human, Rat, Mouse, Pig, Cow |
| Molecular Weight | ~57 kDa (predicted), ~35–39 kDa (observed) |
PRPH2 forms hetero-oligomers with ROM1, which are essential for OS stability. In Rom1−/− mice, PRPH2 overexpression compensates for ROM1 loss, restoring disc enclosure .
| Condition | PRPH2:ROM1 Ratio | Outcome |
|---|---|---|
| Wild-Type (WT) | 2:1 | Normal OS structure |
| Rom1−/− | N/A | Disrupted discs (rescued by PRPH2 OE) |
Pathogenic PRPH2 mutations (e.g., R172W) disrupt complex formation with ROM1, causing aggregation and OS degeneration . Overexpression of wild-type PRPH2 in rds+/− mice improves rod function but not cone defects, highlighting species-specific vulnerabilities .
PRPH2 is a target for gene therapy in retinal degenerations. AAV-mediated delivery of PRPH2 improves OS structure in rod-dominant models (e.g., rds+/− mice), though cone-specific challenges remain .